JNJ-7777120

From Self-sufficiency
Revision as of 06:47, 5 May 2010 by BogBot (Talk) (activated IUPHAR link)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
JNJ-7777120
File:JNJ7777120.png
Systematic (IUPAC) name
5-chloro-2-[(4-methylpiperazin-1-yl)carbonyl]-1H-indole
Identifiers
CAS Number 459168-41-3
PubChem CID 4908365
IUPHAR/BPS 1278
Synonyms 1-[(5-chloro-1H-indol-2-yl)carbonyl]-4-methylpiperazine
Chemical data
Formula C14H16ClN3O
Molar mass 277.749 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

JNJ-7777120 is a drug being developed by Johnson & Johnson Pharmaceutical Research & Development which acts as a potent and selective antagonist at the histamine H4 receptor.[1] It has antiinflammatory effects,[2] and has been demonstrated to be superior to traditional antihistamines in the treatment of pruritus (itching).[3]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />


Stub icon This pharmacology-related article is a stub. You can help ssf by expanding it.
  1. ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  2. ↑ Thurmond RL, Desai PJ, Dunford PJ, Fung-Leung WP, Hofstra CL, Jiang W, Nguyen S, Riley JP, Sun S, Williams KN, Edwards JP, Karlsson L. A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. Journal of Pharmacology and Experimental Therapeutics. 2004 Apr;309(1):404-13. PMID 14722321
  3. ↑ Dunford PJ, Williams KN, Desai PJ, Karlsson L, McQueen D, Thurmond RL. Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. Journal of Allergy and Clinical Immunology. 2007 Jan;119(1):176-83. PMID 17208599
Retrieved from "http://ssf.f15ijp.com/wiki/index.php?title=JNJ-7777120&oldid=24164"